Viral oncolysate in the management of malignant melanoma. I. Preparation of the oncolysate and measurement of immunologic responses.
about
A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoireReplication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical DataSafety and clinical usage of newcastle disease virus in cancer therapyT cell responses to ovarian tumor vaccines: identification and significance for future immunotherapy.An overview on the development of newcastle disease virus as an anti-cancer therapy.Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and HostOncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance.Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy.
P2860
Q24654139-5BA513B7-86C4-4797-AE4D-860A4809716AQ26801501-98A4F5A8-D034-424E-9BD8-AF3D33195709Q35498222-86645152-6619-490A-9D2F-AED57D142A1FQ36542248-60D151D4-A45A-45D6-80FA-23D2703D2903Q36568040-B4D8C228-BFDC-4267-9C5E-A33D6DF94534Q37990940-47166471-4484-48D4-A0A7-A9CA38E2691BQ38369289-B6B53A74-56E6-45BB-87AD-514CDB57D5F8Q38599166-94037256-2029-4F42-8B01-C8B5D4A3522FQ39131669-5C28B091-83D0-443B-9959-5AB6CCC9D4E7
P2860
Viral oncolysate in the management of malignant melanoma. I. Preparation of the oncolysate and measurement of immunologic responses.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Viral oncolysate in the manage ...... ment of immunologic responses.
@en
type
label
Viral oncolysate in the manage ...... ment of immunologic responses.
@en
prefLabel
Viral oncolysate in the manage ...... ment of immunologic responses.
@en
P2093
P1433
P1476
Viral oncolysate in the manage ...... ment of immunologic responses.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(197708)40:2<672::AID-CNCR2820400213>3.0.CO;2-Y
P407
P577
1977-08-01T00:00:00Z